IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients.
Recent genome-wide association studies report that the SNP rs8099917, located 8.9 kb upstream of the start codon of IL28B, is associated with both disease chronicity and therapeutic response to pegIFN-α and RBV in patients infected with genotype 1 HCV. To determine the effect of rs8099917 variation...
Guardado en:
Autores principales: | Ester Aparicio, Mariona Parera, Sandra Franco, Nuria Pérez-Alvarez, Cristina Tural, Bonaventura Clotet, Miguel Angel Martínez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7aefd52a3c1d43afbf25e84ab29cae08 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3.
por: Claus Niederau, et al.
Publicado: (2014) -
Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.
por: Xiwei Wang, et al.
Publicado: (2014) -
Sofosbuvir plus Ribavirin is effective for HCV elimination in people living with HIV from rural area of China
por: Liyu Chen, et al.
Publicado: (2021) -
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Lorena Vigón, et al.
Publicado: (2019) -
Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo.
por: Mohamed Abdel-Mohsen, et al.
Publicado: (2014)